
1. General Information
Veenat 400 mg Tablet is an oral targeted cancer therapy containing Imatinib Mesylate equivalent to 400 mg of Imatinib. It works by blocking abnormal tyrosine kinase proteins involved in the growth and survival of certain cancer cells.
Product: Veenat 400 mg Tablet
Active Ingredient: Imatinib Mesylate 400 mg
Therapeutic Class: Antineoplastic / Tyrosine Kinase Inhibitor
Dosage Form: Film-coated tablet
Manufacturer: Natco Pharma Ltd., India
Route: Oral
Prescription: Required
Phoenix Exim is a pharmaceutical exporter from Nagpur, India, supplying pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable import, prescription and regulatory requirements.
2. Product Information
Veenat 400 mg contains Imatinib, a targeted therapy designed to inhibit specific abnormal proteins that promote uncontrolled cell growth. Official product information identifies 400 mg as an available tablet strength and lists indications including Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), certain Ph+ acute lymphoblastic leukemia (ALL), Kit-positive gastrointestinal stromal tumors (GIST), and other specific conditions.
The exact indication and dose depend on the patient's diagnosis, treatment response, age, laboratory results and physician's treatment plan.
3. Uses of Veenat 400 mg
Veenat 400 mg may be prescribed for specific conditions such as:
- Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML)
- Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
- Kit-positive Gastrointestinal Stromal Tumors (GIST)
- Dermatofibrosarcoma Protuberans (DFSP)
- Certain aggressive systemic mastocytosis cases
- Certain hypereosinophilic syndromes/chronic eosinophilic leukemia
- Other approved indications depending on the patient's clinical condition and local regulatory labeling.
4. Benefits of Veenat 400 mg
When prescribed for an appropriate condition, Veenat 400 mg can:
- Target abnormal proteins involved in cancer-cell growth.
- Help slow or stop the multiplication of certain cancer cells.
- Help control certain forms of CML and other approved cancers.
- Help control or reduce tumor growth in selected GIST patients.
- Provide targeted treatment compared with therapies that act less selectively on cancer cells.
Important: The benefits vary according to the type and stage of disease. It should not be considered a general cancer treatment for every type of cancer.
5. Side Effects of Veenat 400 mg
Possible side effects include:
- Fluid retention or edema
- Nausea
- Vomiting
- Diarrhea
- Abdominal discomfort or pain
- Muscle cramps
- Musculoskeletal pain
- Fatigue
- Skin rash
- Headache
- Dizziness
- Weight gain
More serious reactions can include significant fluid retention, low blood-cell counts, liver toxicity, cardiac problems and kidney-related problems.
Seek medical attention promptly for symptoms such as severe swelling, unusual bleeding, persistent fever, yellowing of the skin or eyes, severe shortness of breath, or rapid unexplained weight gain.
6. Common Side Effects
Commonly reported adverse reactions with imatinib include:
- Edema
- Nausea
- Vomiting
- Muscle cramps
- Musculoskeletal pain
- Diarrhea
- Skin rash
- Fatigue
- Abdominal pain
These reactions do not occur in everyone, and their severity can vary.
7. How to Use Veenat 400 mg
- Take Veenat exactly as prescribed by your oncologist.
- It is generally taken with a meal and a large glass of water to reduce gastrointestinal irritation.
- Swallow the tablet as directed; do not change the prescribed dose yourself.
- Take it at approximately the same time each day if prescribed once daily.
- Do not stop treatment without consulting your doctor, even if you feel better.
- If you miss a dose, follow your physician's or pharmacist's instructions rather than taking an extra dose on your own.
The dosage schedule differs substantially between indications, so 400 mg should not automatically be assumed to be the correct dose for every patient.
8. How Veenat 400 mg Works
Veenat contains Imatinib, a tyrosine kinase inhibitor.
In Ph+ CML, Imatinib blocks the activity of the abnormal BCR-ABL protein associated with the Philadelphia chromosome. In certain GISTs, it inhibits KIT (CD117) signaling. By blocking these abnormal growth signals, Imatinib can reduce the proliferation and survival of susceptible cancer cells.
9. Safety Advice
- Prescription use: Use only under specialist medical supervision.
- Blood tests: Regular complete blood counts may be required because Imatinib can cause anemia, neutropenia or thrombocytopenia.
- Liver monitoring: Liver function should be assessed before treatment and monitored during therapy.
- Fluid retention: Monitor for swelling and unexpected rapid weight gain.
- Heart conditions: Patients with cardiac disease or risk factors require appropriate monitoring.
- Kidney function: Renal function may need monitoring during treatment.
- Pregnancy: Discuss pregnancy plans with your doctor before starting treatment.
- Drug interactions: Tell your doctor about all prescription medicines, OTC medicines, vitamins and herbal products you take.
- Alcohol: Discuss alcohol consumption with your healthcare professional because of potential liver-related concerns.
- Driving: If you experience dizziness or other symptoms affecting alertness, avoid driving or operating machinery.
10. Frequently Asked Questions (FAQs)
Q1. What is Veenat 400 mg Tablet used for?
Veenat 400 mg is used for certain cancers and blood disorders, including specific forms of CML, Ph+ ALL and GIST, among other approved indications.
Q2. What is the active ingredient in Veenat 400 mg?
It contains Imatinib Mesylate equivalent to 400 mg of Imatinib.
Q3. Is Veenat 400 mg a chemotherapy medicine?
It is an oral targeted anticancer therapy belonging to the tyrosine kinase inhibitor class. It works differently from traditional cytotoxic chemotherapy.
Q4. Can I take Veenat 400 mg without a prescription?
No. It is a prescription medicine and should be taken only under appropriate medical supervision.
Q5. Should Veenat 400 mg be taken with food?
Official product information recommends taking Imatinib with a meal and a large glass of water to minimize gastrointestinal disturbances.
Q6. Can I stop Veenat 400 mg when I feel better?
No. Do not stop or alter cancer treatment without consulting your treating physician.
Q7. What are the most common side effects?
Edema, nausea, vomiting, muscle cramps, musculoskeletal pain, diarrhea, rash, fatigue and abdominal pain are among the commonly reported reactions.
Q8. Does everyone with cancer need Veenat 400 mg?
No. Imatinib works against particular molecular targets and is appropriate only for certain diseases and patients.
Q9. Does Veenat 400 mg require regular blood tests?
Yes. Your physician may order regular blood counts and liver-function tests, particularly during treatment.
Q10. Can Veenat 400 mg interact with other medicines?
Yes. Imatinib can interact with other medicines, so provide your doctor with a complete list of everything you take before starting treatment.
11. Substitutes for Veenat 400 mg
Possible alternatives may contain the same active ingredient, Imatinib 400 mg, but they are not automatically interchangeable for every patient or indication.
Examples of Imatinib-containing products may include:
- Imatib 400 mg
- Imatibib 400 mg
- Imatib 400 mg
- Other locally approved Imatinib 400 mg brands/generics
The appropriate substitute should be confirmed by a doctor or pharmacist based on the exact diagnosis, formulation, regulatory approval and availability in the destination country.
12. SEO Keywords
Primary keywords:
- Veenat 400 mg Tablet
- Veenat 400 mg
- Veenat 400 mg Tablet exporter
- Veenat 400 mg supplier
- Veenat 400 mg manufacturer
- Veenat 400 mg wholesale supplier
- Imatinib 400 mg Tablet
- Imatinib Mesylate 400 mg
- Imatinib 400 mg exporter from India
- Imatinib 400 mg pharmaceutical supplier
Long-tail B2B keywords:
- Veenat 400 mg Tablet pharmaceutical exporter from India
- Veenat 400 mg Tablet supplier from Nagpur India
- Veenat 400 mg Imatinib Tablet international supplier
- Veenat 400 mg Tablet wholesale pharmaceutical supplier
- Veenat 400 mg Tablet bulk supply from India
- Imatinib 400 mg Tablet exporter from Nagpur India
- Imatinib Mesylate 400 mg wholesale supplier India
- Imatinib 400 mg pharmaceutical exporter to USA
- Imatinib 400 mg pharmaceutical exporter to UK
- Imatinib 400 mg pharmaceutical exporter to Australia
- Imatinib 400 mg pharmaceutical exporter to Canada
- Imatinib 400 mg pharmaceutical exporter to Singapore
- Imatinib 400 mg pharmaceutical exporter to South Korea
- Imatinib 400 mg pharmaceutical exporter to UAE
- Veenat 400 mg Tablet international pharmaceutical distributor
- Veenat 400 mg Tablet bulk medicine supplier India
- Veenat 400 mg oncology medicine exporter India
- Veenat 400 mg cancer medicine supplier
- Imatinib Mesylate oncology medicine supplier India
- Veenat 400 mg B2B pharmaceutical supplier
Keywords







